Doctorglasses Chain Co Forward P/E
The Forward P/E Ratio of Doctorglasses Chain Co (300622.SZ) as of Sep 29, 2026 is 46.23. In the previous year, Forward P/E Ratio was 66.30 — a change of -30.27% (lower).
Get this data via API
Financial Data API
Forward P/E
46.23
YoY
-30.27%
Last updated:
The Doctorglasses Chain Co Forward P/E history
3 Years
10 Years
25 Years
Max
| YEAR | Forward P/E | YoY |
|---|---|---|
| 46.23 | -30.27% | |
| 66.30 | +23.58% | |
| 53.65 | -40.80% | |
| 90.62 | +25.03% | |
| 72.48 | -27.02% | |
| 99.32 | -9.85% | |
| 110.17 | -4.88% | |
| 115.83 | -12.00% | |
| 131.62 | -27.61% | |
| 181.82 | -6.60% | |
| 194.66 | -3.91% | |
| 202.59 | — |
Doctorglasses Chain Co Stock analysis
Frequently Asked Questions about Doctorglasses Chain Co stock
Forward P/E Ratio of Doctorglasses Chain Co is 46.23 in 2026.
Forward P/E Ratio of Doctorglasses Chain Co changed from 66.30 to 46.23, representing a -30.27% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Forward P/E Ratio Doctorglasses Chain Co since 2006 – with annual values, charts, and detailed analysis.
The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.
To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Doctorglasses Chain Co with sector peers and the industry average to assess whether it is attractive.
Valuation — Doctorglasses Chain Co
All Key Metrics — Doctorglasses Chain Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth